Showing results (331-340 of 760) with videos related to

Sort By:
Pageof 76
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 15, 2014
Liposomal carfilzomib nanoparticles effectively target multiple myeloma cells and demonstrate enhanced efficacy in vivoJonathan D Ashley, Jared F Stefanick, Valerie A Schroeder, et al.
Blood|November 21, 2024
Development of hyperdiploidy starts at an early age and takes a decade to completeMehmet K Samur, Anil Aktas Samur, Parth Shah, et al.
Advanced Healthcare Materials|September 24, 2021
A 3D-Bioprinted Multiple Myeloma ModelDi Wu, Zongyi Wang, Jun Li, et al.
Leukemia|February 16, 2020
A novel BCMA PBD-ADC with ATM/ATR/WEE1 inhibitors or bortezomib induce synergistic lethality in multiple myelomaLijie Xing, Liang Lin, Tengteng Yu, et al.
British Journal of Haematology|November 7, 2008
Bortezomib is associated with better health-related quality of life than high-dose dexamethasone in patients with relapsed multiple myeloma: results from the APEX studyStephanie J Lee, Paul G Richardson, Pieter Sonneveld, et al.
Leukemia & Lymphoma|August 20, 2011
A phase 1 study of IPI-504 (retaspimycin hydrochloride) in patients with relapsed or relapsed and refractory multiple myelomaDavid Siegel, Sundar Jagannath, David H Vesole, et al.
Blood Cancer Discovery|February 4, 2026
Rethinking Multiple Myeloma Treatment: The Biological and Clinical Insights Guiding Immune-Based CombinationsAnnamaria Gullà, Madhav V Dhodapkar, Hermann Einsele, et al.
Blood|August 30, 2002
2-Methoxyestradiol overcomes drug resistance in multiple myeloma cellsDharminder Chauhan, Laurence Catley, Teru Hideshima, et al.
Cancer Research|July 3, 2004
In vitro and in vivo activity of the maytansinoid immunoconjugate huN901-N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-maytansine against CD56+ multiple myeloma cellsPierfrancesco Tassone, Antonella Gozzini, Victor Goldmacher, et al.
Blood|July 16, 2005
Clinical factors predictive of outcome with bortezomib in patients with relapsed, refractory multiple myelomaPaul Gerard Guy Richardson, Bart Barlogie, James Berenson, et al.
Pageof 76